JAMA JAMA is an international peer-reviewed general medical journal published weekly online and in print.
(1581)

The official page for JAMA http://jama.com, an international, peer-reviewed journal published weekly online and in print.

📊 JAMA Guide to Statistics and Methods: The win ratio is a statistical method for hierarchical composite outcomes, offer...
01/28/2026

📊 JAMA Guide to Statistics and Methods: The win ratio is a statistical method for hierarchical composite outcomes, offering a patient-centered summary of treatment effects by prioritizing more important clinical events in clinical trials.

https://ja.ma/49LxJre

💬 Editor's Note by JAMA Deputy Editors Preeti Malani, MD, MSJ, and Joseph Ross, MD, MHS: As generative   tools become mo...
01/28/2026

💬 Editor's Note by JAMA Deputy Editors Preeti Malani, MD, MSJ, and Joseph Ross, MD, MHS: As generative tools become more advanced and accessible, transparent reporting and updated editorial guidance are needed to ensure research integrity.

https://ja.ma/4qeeiwg

A cross-sectional analysis of research manuscripts submitted to 49 BMJ journals between April and November 2024 found th...
01/28/2026

A cross-sectional analysis of research manuscripts submitted to 49 BMJ journals between April and November 2024 found that 5.7% included author-declared use of artificial intelligence ( ).

Chatbots were the most frequently reported tools, with writing assistants also commonly used. Most authors applied to improve writing quality, and disclosure rates increased over the study period.

https://ja.ma/4aietld

Among more than 100 000 manuscripts submitted to 13 JAMA Network journals from August 2023 through October 2025, 3.3% in...
01/28/2026

Among more than 100 000 manuscripts submitted to 13 JAMA Network journals from August 2023 through October 2025, 3.3% included author-declared use of artificial intelligence ( ), with reported use rising from 1.7% to nearly 6% over this period.

The most common reason for use was language refinement, while statistical modeling, data analysis, manuscript drafting, and literature search were also reported.

Manuscripts from non–English-speaking countries, those ultimately withdrawn or rejected, and certain article types were more likely to disclose AI involvement, highlighting the expanding role of in medical research and the need for ongoing policy guidance.

https://ja.ma/3MbkOWr

From 1990 to 2022, the US adult obesity rate increased from 19.3% to 42.5%, affecting more than 100 million adults. Proj...
01/28/2026

From 1990 to 2022, the US adult obesity rate increased from 19.3% to 42.5%, affecting more than 100 million adults.

Projections estimate that by 2035, nearly 47% of adults will have , with sharper increases among younger adults and persistent differences across states and s*x and racial and ethnic groups. The highest prevalence occurs among non-Hispanic Black females and in Southern and Midwestern states, underscoring ongoing public health and clinical challenges.

https://ja.ma/45xCSR7

💬 Viewpoint: The 2025-2030 Dietary Guidelines for Americans weakened evidence-based recommendations for plant-predominan...
01/28/2026

💬 Viewpoint: The 2025-2030 Dietary Guidelines for Americans weakened evidence-based recommendations for plant-predominant diets, potentially impacting efforts to reduce disease, , and .

https://ja.ma/4k6U6uP

📊 Research Summary: In adults with   and daily to***co use, an mHealth intervention delivering motivational and behavior...
01/28/2026

📊 Research Summary: In adults with and daily to***co use, an mHealth intervention delivering motivational and behavioral support via text message led to higher quit rates at 6 months compared to written advice.

https://ja.ma/4kn6sz7

💬 Editorial: A randomized trial in Bangladesh and Pakistan found an mHealth text message–based cessation program, delive...
01/28/2026

💬 Editorial: A randomized trial in Bangladesh and Pakistan found an mHealth text message–based cessation program, delivered in local languages, tripled biochemically verified abstinence rates among patients with compared to usual care.

The intervention, integrated into routine TB clinic workflows, proved scalable and cost-effective, supporting immediate implementation in high-burden settings.

https://ja.ma/4a4zwqg

Among adults with newly diagnosed, drug-sensitive   in high-burden countries, an mHealth program delivering text message...
01/28/2026

Among adults with newly diagnosed, drug-sensitive in high-burden countries, an mHealth program delivering text messages for to***co cessation was associated with higher quit rates and lower short-term mortality than written advice alone.

These findings demonstrate that mHealth approaches are feasible and effective for smoking cessation in tuberculosis patients where access to traditional cessation treatment is limited.

https://ja.ma/4a0RtG7

📌 Editor’s Choice from this week's issue of JAMA:➡️ Coffee to Reduce AFib Recurrence (DECAF),➡️ Therapeutic Use of Canna...
01/27/2026

📌 Editor’s Choice from this week's issue of JAMA:

➡️ Coffee to Reduce AFib Recurrence (DECAF),
➡️ Therapeutic Use of Cannabis and Cannabinoids Review,
➡️ Dialysis Strategies To Improve Kidney Recovery in AKI, and more.

ja.ma/4eRp9GH

  is a common disease among older adults that weakens bones and increases the likelihood of fractures.  Worldwide, 1 in ...
01/27/2026

is a common disease among older adults that weakens bones and increases the likelihood of fractures.

Worldwide, 1 in 3 women and 1 in 5 men older than 50 years have a bone fracture due to osteoporosis during their lifetime.

📄 This JAMA Patient Page describes osteoporosis risk factors, symptoms, screening, diagnosis, and treatment.

https://ja.ma/461ZiKq

Approximately 27% of adults in the US and Canada report having ever used   for medical purposes. An estimated 10.5% of t...
01/27/2026

Approximately 27% of adults in the US and Canada report having ever used for medical purposes. An estimated 10.5% of the US population reports using cannabidiol (CBD), a chemical compound extracted from cannabis that does not have psychoactive effects, for therapeutic purposes.

📌 This Review summarizes current evidence about the therapeutic use of cannabis and cannabinoids in adults, potential harms, and evidence-based clinical guidance, including pretreatment screening and addressing preexisting cannabis use in clinical settings.

https://ja.ma/4rizSRa

Address

330 N Wabash Avenue
Chicago, IL
60611

Telephone

+13126707827

Alerts

Be the first to know and let us send you an email when JAMA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram